These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18177202)

  • 1. The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United States.
    Gagnon MA; Lexchin J
    PLoS Med; 2008 Jan; 5(1):e1. PubMed ID: 18177202
    [No Abstract]   [Full Text] [Related]  

  • 2. Deconstructing Myogen's market cap.
    Ransom J
    Nat Biotechnol; 2006 Mar; 24(3):227-8. PubMed ID: 16525363
    [No Abstract]   [Full Text] [Related]  

  • 3. US drug marketing: how does promotion correspond with health value?
    Greenway T; Ross JS
    BMJ; 2017 May; 357():j1855. PubMed ID: 28465309
    [No Abstract]   [Full Text] [Related]  

  • 4. Excess in the pharmaceutical industry.
    Angell M
    CMAJ; 2004 Dec; 171(12):1451-3. PubMed ID: 15583183
    [No Abstract]   [Full Text] [Related]  

  • 5. Biotech drug market steadily expands.
    Lawrence S
    Nat Biotechnol; 2005 Dec; 23(12):1466. PubMed ID: 16333279
    [No Abstract]   [Full Text] [Related]  

  • 6. Small-area variations in sales of TNF inhibitors in Sweden between 2000 and 2009: comments on the article by M Neovius et al.
    Ohlsson H; Merlo J
    Scand J Rheumatol; 2011 May; 40(3):243-4. PubMed ID: 21529245
    [No Abstract]   [Full Text] [Related]  

  • 7. The association of pharmaceutical company promotional spending with resident physician prescribing behavior.
    Huang FY; Weiss DS; Fenimore PG; Fleming AM; Haller E; Lichtmacher JE; Eisendrath SJ
    Acad Psychiatry; 2005; 29(5):500-1. PubMed ID: 16387978
    [No Abstract]   [Full Text] [Related]  

  • 8. The biotech drug market.
    Lawrence S
    Nat Biotechnol; 2004 Dec; 22(12):1496. PubMed ID: 15583645
    [No Abstract]   [Full Text] [Related]  

  • 9. Does Increased Spending on Pharmaceutical Marketing Inhibit Pioneering Innovation?
    Arnold DG; Troyer JL
    J Health Polit Policy Law; 2016 Apr; 41(2):157-79. PubMed ID: 26732315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical promotion and GP prescription behaviour.
    Windmeijer F; de Laat E; Douven R; Mot E
    Health Econ; 2006 Jan; 15(1):5-18. PubMed ID: 15945041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicine and the pharmaceutical industry: what's right, what's wrong, and what's to come.
    Tan SY
    Singapore Med J; 1998 Mar; 39(3):91-5. PubMed ID: 9632964
    [No Abstract]   [Full Text] [Related]  

  • 12. The gift of drug samples.
    Reid EE
    Hastings Cent Rep; 2012; 42(2):49. PubMed ID: 22733332
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug firms cut doctors' fees for drug talks.
    McCarthy M
    BMJ; 2014 Mar; 348():g2021. PubMed ID: 24607478
    [No Abstract]   [Full Text] [Related]  

  • 14. Take your pills, all your pills: drug makers nag patients to stay the course.
    Pollack A
    N Y Times Web; 2006 Mar; ():C1, C13. PubMed ID: 16649271
    [No Abstract]   [Full Text] [Related]  

  • 15. Asymmetric responsiveness of physician prescription behavior to drug promotion of competitive brands within an established therapeutic drug class.
    Pedan A; Wu H
    Health Mark Q; 2011 Apr; 28(2):133-54. PubMed ID: 21590561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A change in the market--investing in diagnostics.
    Batchelder K; Miller P
    Nat Biotechnol; 2006 Aug; 24(8):922-6. PubMed ID: 16900131
    [No Abstract]   [Full Text] [Related]  

  • 17. Mammalian cell cultures for biologics manufacturing.
    Kantardjieff A; Zhou W
    Adv Biochem Eng Biotechnol; 2014; 139():1-9. PubMed ID: 24258145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Pharmaceutical Industry Marketing of Stimulants, 2014 Through 2018.
    Hadland SE; Cerdá M; Earlywine JJ; Krieger MS; Anderson TS; Marshall BDL
    JAMA Pediatr; 2020 Apr; 174(4):385-387. PubMed ID: 31961384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sample medications and the uninsured.
    Hubbard MJ
    J Am Board Fam Pract; 2003; 16(1):87. PubMed ID: 12583660
    [No Abstract]   [Full Text] [Related]  

  • 20. Marketing drugs: debating the real cost. Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts.
    Brand R
    State Legis; 2008 Sep; 34(8):26-9. PubMed ID: 18754159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.